IP Library › Granted Patent US 7,833,597
Granted Patent B2
US 7,833,597 · App. 11/877,905 · Granted Nov 16, 2010

Polymeric marker with high radiopacity for use in medical devices

Assignee: Advanced Cardiovascular Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,833,597
App. No.
11/877,905
Granted
Nov 16, 2010
Kind
B2
Abstract

High radiopacity is achieved in a polymeric marker by combining a polymeric resin, a powdered radiopaque agent having uniformly shaped particles of a specific particle size distribution and a wetting agent. The method to produce the marker calls for the blending and pelletization of these materials followed by extrusion onto support beading. The resulting supported tubing is subsequently cut to length with the beading still in place. After ejection of the beading remnant the marker is slipped into place on the device to be marked and attached by melt bonding. Marking of a guidewire allows lesions to be measured while the marking of balloon catheters allow the balloon to be properly positioned relative to a lesion.

Claims (7)

1. An intraluminal medical device, comprising an elongated shaft or core member having a radiopaque marker circular band secured to a surface of the shaft or core member, and the radiopaque marker is formed of a compounded polymer mixture comprising:

a) a polymer;

b) radiopaque particles having an average diameter of at least about 2 microns and a maximum diameter of about 20 microns, the radiopaque particles comprising about 90.8 to about 93.2 weight percent of the compounded polymer mixture; and

c) a wetting agent for facilitating encapsulation of said particles by said polymer, and wherein the marker band has a radiopacity that is substantially constant along the length of the marker band, and a double wall thickness that varies by less than 0.001 inches along the entire length of the marker band.

2. The intraluminal medical device of claim 1 wherein the double wall thickness of the radiopaque marker is about 0.004 to about 0.006 inches.

3. The intraluminal medical device of claim 1 wherein the double wall thickness of the radiopaque marker varies by about ±0.0005 inches along the entire length of the marker band.

4. The intraluminal medical device of claim 1 wherein the radiopaque marker is secured to the shaft or core member with an adhesive.

Continuity (3)
Division 1094563700 · Sep 21, 2004
Continuation In Part 1066771000 · Sep 22, 2003
Related Publication 20080065010A1 · Mar 13, 2008